Yahoo Web Search

Search results

    • Goldman downgrades Enfusion Inc

      Knox Daily· 60 minutes ago

      Goldman downgraded its Enfusion Inc [ENFN] rating to a Sell from a a Neutral in a research note published on February 28, 2024; the price target was decreased to $8 from $9